Form 4 Tracker
BIOCRYST PHARMACEUTICALS INC
BCRX

19 insider filings · Latest: Jun 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 18, 2026May 19 4:07 PMAmy E MckeeDirector
Sale
11,180$8.97$100.3K31,252(D)

View →

May 13, 2026May 15 4:08 PMAlane P BarnesChief Legal Officer
Sale
62,500$9.54$596.3K400,703(D)

View →

Mar 20, 2026Mar 24 4:02 PMTheresa HeggieDirector
Sale
49,933$10.11$504.8K65,352(D)

View →

Mar 16, 2026Mar 18 4:11 PMAlane P BarnesChief Legal Officer
Sale
150,000$9.15$1.4M400,703(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 11, 2026Jun 15 4:32 PMJill C. MilneDirector
Grant/Award
33,540$8.5033,540(D)

View →

Jun 11, 2026Jun 15 4:30 PMSteven K GalsonDirector
Grant/Award
33,540$8.5033,540(D)

View →

Jun 11, 2026Jun 15 4:29 PMAlan G LevinDirector
Grant/Award
33,540$8.5033,540(D)

View →

Jun 11, 2026Jun 15 4:16 PMSteven FrankDirector
Grant/Award
33,540$8.5033,540(D)

View →

Jun 11, 2026Jun 15 4:14 PMMachelle SandersDirector
Grant/Award
33,540$8.5033,540(D)

View →

Jun 11, 2026Jun 15 4:12 PMVincent MilanoDirector
Grant/Award
33,540$8.5033,540(D)

View →

Jun 11, 2026Jun 15 4:10 PMJon P StonehouseDirector
Grant/Award
33,540$8.5033,540(D)

View →

Jun 11, 2026Jun 15 4:08 PMAmy E MckeeDirector
Grant/Award
33,540$8.5033,540(D)

View →

Jun 11, 2026Jun 15 4:06 PMTheresa HeggieDirector
Grant/Award
33,540$8.5033,540(D)

View →

May 13, 2026May 15 4:08 PMAlane P BarnesChief Legal Officer
Option Exercise
62,500$5.040(D)

View →

Apr 6, 2026Apr 7 4:24 PMSandeep MenonChief R&D Officer
Grant/Award
441,350$9.47441,350(D)

View →

Mar 20, 2026Mar 24 4:02 PMTheresa HeggieDirector
Option Exercise
49,933$6.300(D)

View →

Mar 16, 2026Mar 18 4:11 PMAlane P BarnesChief Legal Officer
Option Exercise
150,000$5.510(D)

View →